Cold and Cough Relief Tablet in pharma franchise in Haryana

Cold and Cough Relief Tablet in PCD pharma franchise in Imphal

Cold and Cough Relief Tablet in top pharma company in Srinagar

Cold and Cough Relief Tablet in pcd pharma supplier in Solapur

Cold and Cough Relief Tablet in phama franchise company in India
Cold and Cough Relief Tablet in phama distributor in Tirupati

Home/Products /ambroxol-30mg-cetirizine-5mg-dextromethorphan-tablet

About the Product

Description


Cufsniff AD Tablet is a combination medication designed to address symptoms associated with respiratory conditions like cough, congestion, and mucus production. This formulation combines the benefits of Ambroxol, Cetirizine, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine to provide effective relief from various symptoms of cold and cough. It belongs to the Cold and Cough therapy category and is a part of the General medicines range.

Cufsniff AD Tablet is a well-rounded solution for managing symptoms of cough and cold. Here's how each ingredient contributes to its effectiveness:

  • Ambroxol (30mg): A mucolytic agent that thins and loosens mucus, making it easier to expel and alleviating chest congestion.
  • Cetirizine (5mg): An antihistamine that helps relieve allergy symptoms like sneezing, runny nose, and itching by blocking histamine release.
  • Dextromethorphan Hydrobromide (10mg): A cough suppressant that acts on the cough center in the brain to reduce the frequency of dry cough.
  • Guaifenesin (100mg): An expectorant that increases mucus secretion in the respiratory tract, facilitating its removal and improving breathing.
  • Phenylephrine (15mg): A nasal decongestant that reduces swelling in the nasal passages, easing breathing and relieving stuffiness.

This synergistic formulation is ideal for addressing both productive and dry cough, nasal congestion, and allergy symptoms.

Common side effects may include: Drowsiness or dizziness Dry mouth Mild gastrointestinal discomfort Increased heart rate or palpitations (rare) If severe side effects occur, such as difficulty breathing or persistent dizziness, seek medical attention promptly.

Cufsniff AD Tablet is indicated for managing symptoms of common cold, allergic rhinitis, bronchitis, and respiratory tract infections that involve cough, nasal congestion, and mucus build-up.

Use under the supervision of a healthcare professional. Not suitable for individuals with known allergies to any of the ingredients. Avoid alcohol consumption as it may enhance drowsiness. Not recommended for children under 12 years without medical advice.

Store the medication in a cool, dry place below 25°C. Keep it out of reach of children and away from direct sunlight.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Ambroxol 30mg + Cetirizine 5mg + Dextromethorphan Tablet in the PCD pharma franchise market?

This combination tablet has strong demand in the respiratory and cough-care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on seasonal cold, cough, and allergy portfolios.

Why should medical distributors include this combination tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for multi-action cough therapy used in dry cough, allergic cough, common cold, throat irritation, and chest congestion. Ambroxol helps clear mucus, Cetirizine reduces allergy symptoms, and Dextromethorphan suppresses cough reflex, strengthening a comprehensive respiratory care product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for this combination tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong seasonal demand, high prescription flow during cold & flu season, OTC + prescription usage, reliable supply chain support, and good margins when partnering for this respiratory combination product.

How can I become a distributor or franchise partner for this tablet?

Medical distributors, stockists, and wholesalers interested in Ambroxol + Cetirizine + Dextromethorphan Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.